Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Growth (Status and Outlook) 2025-2031

September 2025 | 97 pages | ID: GFB988F29225EN
LP Information

Abstracts

According to this study, the global Prostate Specific Antigen (PSA) Blood Based Biomarker market size will reach US$ million by 2031.

Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis.

United States market for Prostate Specific Antigen (PSA) Blood Based Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Prostate Specific Antigen (PSA) Blood Based Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Prostate Specific Antigen (PSA) Blood Based Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Prostate Specific Antigen (PSA) Blood Based Biomarker players cover ProteoMediX, Cleveland Diagnostics, Randox, Roche, GENFIT, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Prostate Specific Antigen (PSA) Blood Based Biomarker Industry Forecast” looks at past sales and reviews total world Prostate Specific Antigen (PSA) Blood Based Biomarker sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostate Specific Antigen (PSA) Blood Based Biomarker sales for 2025 through 2031. With Prostate Specific Antigen (PSA) Blood Based Biomarker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate Specific Antigen (PSA) Blood Based Biomarker industry.

This Insight Report provides a comprehensive analysis of the global Prostate Specific Antigen (PSA) Blood Based Biomarker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prostate Specific Antigen (PSA) Blood Based Biomarker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate Specific Antigen (PSA) Blood Based Biomarker market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate Specific Antigen (PSA) Blood Based Biomarker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate Specific Antigen (PSA) Blood Based Biomarker.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Specific Antigen (PSA) Blood Based Biomarker market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Screening Biomarker
• Diagnosis Biomarker

Segmentation by Application:

• Diagnostics
• Drug Discovery
• Personalized Medicine
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• ProteoMediX
• Cleveland Diagnostics
• Randox
• Roche
• GENFIT
• Nutech Cancer Biomarkers
• OGT (Sysmex Group)
• Minomic
• Creative Diagnostics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2020-2031)
  2.1.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Prostate Specific Antigen (PSA) Blood Based Biomarker by Country/Region (2020, 2024 & 2031)
2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Segment by Type
  2.2.1 Screening Biomarker
  2.2.2 Diagnosis Biomarker
2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
  2.3.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2020-2025)
2.4 Prostate Specific Antigen (PSA) Blood Based Biomarker Segment by Application
  2.4.1 Diagnostics
  2.4.2 Drug Discovery
  2.4.3 Personalized Medicine
  2.4.4 Others
2.5 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
  2.5.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2020-2025)

3 PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET SIZE BY PLAYER

3.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Player
  3.1.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Player (2020-2025)
  3.1.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Player (2020-2025)
3.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER BY REGION

4.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2020-2025)
4.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth (2020-2025)
4.4 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth (2020-2025)
4.5 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth (2020-2025)
4.6 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2020-2025)
5.2 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2020-2025)
5.3 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2020-2025)
6.2 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2020-2025)
6.3 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2020-2025)
7.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2020-2025)
7.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker by Region (2020-2025)
8.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2020-2025)
8.3 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER MARKET FORECAST

10.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Region (2026-2031)
  10.1.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Region (2026-2031)
  10.1.2 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.1.3 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.1.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.1.5 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
10.2 Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Country (2026-2031)
  10.2.1 United States Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.2.2 Canada Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.2.3 Mexico Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.2.4 Brazil Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
10.3 APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Region (2026-2031)
  10.3.1 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast
  10.3.2 Japan Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.3.3 Korea Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.3.4 Southeast Asia Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.3.5 India Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.3.6 Australia Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
10.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Country (2026-2031)
  10.4.1 Germany Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.4.2 France Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.4.3 UK Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.4.4 Italy Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.4.5 Russia Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
10.5 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Region (2026-2031)
  10.5.1 Egypt Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.5.2 South Africa Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.5.3 Israel Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
  10.5.4 Turkey Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast
10.6 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Type (2026-2031)
10.7 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Prostate Specific Antigen (PSA) Blood Based Biomarker Forecast

11 KEY PLAYERS ANALYSIS

11.1 ProteoMediX
  11.1.1 ProteoMediX Company Information
  11.1.2 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
  11.1.3 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 ProteoMediX Main Business Overview
  11.1.5 ProteoMediX Latest Developments
11.2 Cleveland Diagnostics
  11.2.1 Cleveland Diagnostics Company Information
  11.2.2 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
  11.2.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Cleveland Diagnostics Main Business Overview
  11.2.5 Cleveland Diagnostics Latest Developments
11.3 Randox
  11.3.1 Randox Company Information
  11.3.2 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
  11.3.3 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Randox Main Business Overview
  11.3.5 Randox Latest Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
  11.4.3 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Roche Main Business Overview
  11.4.5 Roche Latest Developments
11.5 GENFIT
  11.5.1 GENFIT Company Information
  11.5.2 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
  11.5.3 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 GENFIT Main Business Overview
  11.5.5 GENFIT Latest Developments
11.6 Nutech Cancer Biomarkers
  11.6.1 Nutech Cancer Biomarkers Company Information
  11.6.2 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
  11.6.3 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Nutech Cancer Biomarkers Main Business Overview
  11.6.5 Nutech Cancer Biomarkers Latest Developments
11.7 OGT (Sysmex Group)
  11.7.1 OGT (Sysmex Group) Company Information
  11.7.2 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
  11.7.3 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 OGT (Sysmex Group) Main Business Overview
  11.7.5 OGT (Sysmex Group) Latest Developments
11.8 Minomic
  11.8.1 Minomic Company Information
  11.8.2 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
  11.8.3 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Minomic Main Business Overview
  11.8.5 Minomic Latest Developments
11.9 Creative Diagnostics
  11.9.1 Creative Diagnostics Company Information
  11.9.2 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
  11.9.3 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Creative Diagnostics Main Business Overview
  11.9.5 Creative Diagnostics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Prostate Specific Antigen (PSA) Blood Based Biomarker Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Screening Biomarker
Table 4. Major Players of Diagnosis Biomarker
Table 5. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2020-2025)
Table 8. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2020-2025)
Table 11. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Player (2020-2025)
Table 13. Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players Head office and Products Offered
Table 14. Prostate Specific Antigen (PSA) Blood Based Biomarker Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Region (2020-2025)
Table 19. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Country (2020-2025)
Table 23. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2020-2025)
Table 25. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2020-2025)
Table 27. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Region (2020-2025)
Table 29. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Country (2020-2025)
Table 33. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Prostate Specific Antigen (PSA) Blood Based Biomarker
Table 39. Key Market Challenges & Risks of Prostate Specific Antigen (PSA) Blood Based Biomarker
Table 40. Key Industry Trends of Prostate Specific Antigen (PSA) Blood Based Biomarker
Table 41. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. ProteoMediX Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 46. ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 47. ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. ProteoMediX Main Business
Table 49. ProteoMediX Latest Developments
Table 50. Cleveland Diagnostics Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 51. Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 52. Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Cleveland Diagnostics Main Business
Table 54. Cleveland Diagnostics Latest Developments
Table 55. Randox Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 56. Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 57. Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Randox Main Business
Table 59. Randox Latest Developments
Table 60. Roche Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 61. Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 62. Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Roche Main Business
Table 64. Roche Latest Developments
Table 65. GENFIT Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 66. GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 67. GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. GENFIT Main Business
Table 69. GENFIT Latest Developments
Table 70. Nutech Cancer Biomarkers Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 71. Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 72. Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Nutech Cancer Biomarkers Main Business
Table 74. Nutech Cancer Biomarkers Latest Developments
Table 75. OGT (Sysmex Group) Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 76. OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 77. OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. OGT (Sysmex Group) Main Business
Table 79. OGT (Sysmex Group) Latest Developments
Table 80. Minomic Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 81. Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 82. Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Minomic Main Business
Table 84. Minomic Latest Developments
Table 85. Creative Diagnostics Details, Company Type, Prostate Specific Antigen (PSA) Blood Based Biomarker Area Served and Its Competitors
Table 86. Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product Offered
Table 87. Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Creative Diagnostics Main Business
Table 89. Creative Diagnostics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Prostate Specific Antigen (PSA) Blood Based Biomarker Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Prostate Specific Antigen (PSA) Blood Based Biomarker Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Country/Region (2024)
Figure 8. Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type in 2024
Figure 10. Prostate Specific Antigen (PSA) Blood Based Biomarker in Diagnostics
Figure 11. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market: Diagnostics (2020-2025) & ($ millions)
Figure 12. Prostate Specific Antigen (PSA) Blood Based Biomarker in Drug Discovery
Figure 13. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market: Drug Discovery (2020-2025) & ($ millions)
Figure 14. Prostate Specific Antigen (PSA) Blood Based Biomarker in Personalized Medicine
Figure 15. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market: Personalized Medicine (2020-2025) & ($ millions)
Figure 16. Prostate Specific Antigen (PSA) Blood Based Biomarker in Others
Figure 17. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market: Others (2020-2025) & ($ millions)
Figure 18. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application in 2024
Figure 19. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Player in 2024
Figure 20. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Region (2020-2025)
Figure 21. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2020-2025 ($ millions)
Figure 22. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2020-2025 ($ millions)
Figure 23. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2020-2025 ($ millions)
Figure 25. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Value Market Share by Country in 2024
Figure 26. United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Region in 2024
Figure 31. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2020-2025)
Figure 32. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2020-2025)
Figure 33. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 37. India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Country in 2024
Figure 40. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2020-2025)
Figure 41. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2020-2025)
Figure 42. Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 43. France Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 56. APAC Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 57. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 59. United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 60. Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 61. Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 62. Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 63. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 64. Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 65. Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 67. India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 68. Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 69. Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 70. France Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 71. UK Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 72. Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 73. Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 74. Egypt Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 75. South Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 76. Israel Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 77. Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)
Figure 78. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size 2026-2031 ($ millions)